Atlas Trials

Safety Evaluation of Dexmedetomidine for EBUS-TBNA

Clinical trial NCT01381627 · UNKNOWN

Trial details

NCT number
NCT01381627
Sponsor
Maisonneuve-Rosemont Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Lung Cancer
Start date
2011-06-01
Primary completion
2013-06-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.